November 2009: On 20 November 2009 SIX listed biotech company Newron Pharmaceuticals S.p.A. has announced that it has raised gross proceeds of CHF7.9m through a private placement to institutional investors. The private placement was conducted without preferential subscription rights to institutional investors and was managed by Jefferies International. The subscription price was set at CHF18.00 per share, representing a 3.23 % discount to the closing price of Newron’s shares on 19 November 2009 of CHF 18.60.

Niederer Kraft & Frey AG acted as Swiss counsel and listing agent of Newron. The NKF team included Philippe Weber and Andrea Huber.